Therapeutic anti-HER2 antibody fusion polypeptides

Details for Australian Patent Application No. 2006338562 (hide)

Owner Genentech, Inc.

Inventors Fong, Sherman; Hu, Zhilan

Agent Griffith Hack

Pub. Number AU-A-2006338562

PCT Pub. Number WO2007/097812

Priority 60/733,441 03.11.05 US

Filing date 1 November 2006

Wipo publication date 30 August 2007

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/097812 Priority application(s): WO2007/097812

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006338566-Time-lapse cell cycle analysis of unstained nuclei

2006338561-Capacitor strap